title: Early ovarian cancer and the icon trials.
authors.forename: D
authors.initials: D
authors.lastname: Ghersi
authors.forename: M K
authors.initials: MK
authors.lastname: Parmar
authors.forename: L A
authors.initials: LA
authors.lastname: Stewart
authors.forename: S
authors.initials: S
authors.lastname: Marsoni
authors.forename: C J
authors.initials: CJ
authors.lastname: Williams
mesh_terms: D000465:Algorithms; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D002945:Cisplatin